Antimicrobial peptides: Their physicochemical properties and therapeutic application

Archives of Pharmacal Research

Volumn 35, Issue 3, 2012, Pages 409-413

  Kang, Su Jin ^a   Kim, Do Hee ^a   Mishig Ochir, Tsogbadrakh ^b   Lee, Bong Jin ^a  

^a Seoul National University   (South Korea)

^b NATIONAL UNIVERSITY OF MONGOLIA   (Mongolia)

Author keywords

Antimicrobial peptides; Mode of action; Physicochemical properties; Therapeutic activity

Indexed keywords

ALPHA DEFENSIN; ANTIBIOTIC AGENT; BREVININ; DROSOCIN; ESCULENTIN 1; HISTATIN 5; INDOLICIDIN; ISEGANAN; LACTOFERRICIN B; MAGAININ 1; NORFLOXACIN; OMIGANAN; PARASIN I; PEXIGANAN; POLYPEPTIDE ANTIBIOTIC AGENT; RANALEXIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEVICE INFECTION; DRUG MARKETING; FOOT ULCER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST PARASITE INTERACTION; HUMAN; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN DEGRADATION; REVIEW; SAFETY;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 84862857245     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0302-9     Document Type: Review

References (33)

1. Andres, E. and Dimarcq, J. L., Cationic antimicrobial peptides: update of clinical development. J. Intern. Med., 255, 519-520 (2004).
2. Beutler, B., Innate immunity: an overview. Mol. Immunol., 40, 845-859 (2004).
3. Boman, H. G., Innate immunity and the normal microflora. Immunol. Rev., 173, 5-16 (2000).
4. Boman, H. G., Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med., 254, 197-215 (2003).
5. Brogden, K. A., Ackermann, M., Mccray, P. B., Jr., and Tack, B. F., Antimicrobial peptides in animals and their role in host defences. Int. J. Antimicrob. Agents, 22, 465-478 (2003).
6. Davis, B. D., Dulbecco, R., Eisen, H. N., Ginsberg, H. S., Wood, W. B., and Mccarty, M., Microbiology, 2nd ed. Harper & Row, Hagerstown, MD, (1973).
7. Dawson, R. M. and Liu, C. Q., Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Crit. Rev. Microbiol., 34, 89-107 (2008).
8. Di Giulio, A. and Zhao, H., Antiomicrobial peptides: Basic mechanisms of action and emerging pharmacological interest. Asian Journal of Biochemistry, 1, 28-40 (2006).
9. Dickma, D. J., Brueggemann, A. B., and Doern, G. V., Antimicrobial- drug use and changes in resistance in Streptococcus pneumoniae. Emerg. Infect. Dis., 6, 552-556 (2000).
10. Gallo, R. L. and Nizet, V., Endogenous production of antimicrobial peptides in innate immunity and human disease. Curr. Allergy Asthma Rep., 3, 402-409 (2003).
11. Giles, F. J., Redman, R., Yazji, S., and Bellm, L., Iseganan HCl: a novel antimicrobial agent. Expert Opin. Investig. Drugs, 11, 1161-1170 (2002).
12. Gordon, Y. J., Romanowski, E. G., and Mcdermott, A. M. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res., 30, 505-515 (2005).
13. Hancock, R. E. and Lehrer, R., Cationic peptides: a new source of antibiotics. Trends Biotechnol., 16, 82-88 (1998).
14. Hancock, R. E., Cationic antimicrobial peptides: towards clinical applications. Expert Opin. Investig. Drugs, 9, 1723-1729 (2000).
15. Hancock, R. E. and Scott, M. G., The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U. S. A., 97, 8856-8861 (2000).
16. Huang, H. W., Action of antimicrobial peptides: two-state model. Biochemistry, 39, 8347-8352 (2000).
17. Huang, Y., Huang, J., and Chen, Y., Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell, 1, 143-152 (2010).
18. Kang, S. J., Won, H. S., Choi, W. S., and Lee, B. J., De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. J. Pept. Sci., 15, 583-588 (2009).
19. Marr, A. K., Gooderham, W. J., and Hancock, R. E., Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol., 6, 468-472 (2006).
20. Matsuzaki, K., Sugishita, K., Harada, M., Fujii, N., and Miyajima, K., Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gramnegative bacteria. Biochim. Biophys. Acta, 1327, 119-130 (1997).
21. Moberg, C. L. and Cohn, Z. A., Lauching the antibiotic era. Personal accounts of the discovery and use of the first antibiotics. Rockefeller University Press, New York, (1990).
22. Moore, A., The big and small of drug discovery. Biotech versus pharma: advantages and drawbacks in drug development. EMBO Rep., 4, 114-117 (2003).
23. Oren, Z., Hong, J., and Shai, Y., A comparative study on the structure and function of a cytolytic alpha-helical peptide and its antimicrobial beta-sheet diastereomer. Eur. J. Biochem., 259, 360-369 (1999).
24. Pereira, H. A., Novel therapies based on cationic antimicrobial peptides. Curr. Pharm. Biotechnol., 7, 229-234 (2006).
25. Shai, Y., Mode of action of membrane active antimicrobial peptides. Biopolymers, 66, 236-248 (2002).
26. Splith, K. and Neundorf, I., Antimicrobial peptides with cellpenetrating peptide properties and vice versa. Eur. Biophys. J., 40, 387-397 (2011).
27. Van 'T Hof, W., Veerman, E. C., Helmerhorst, E. J., and Amerongen, A. V., Antimicrobial peptides: properties and applicability. Biol. Chem., 382, 597-619 (2001).
28. Wang, G., Li, X., and Wang, Z., APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res., 37, D933-D937 (2009).
29. Wang, Z. and Wang, G., APD: the Antimicrobial Peptide Database. Nucleic Acids Res., 32, D590-D592 (2004).
30. Witte, W., Medical consequences of antibiotic use in agriculture. Science, 279, 996-997 (1998).
31. Won, H. S., Kang, S. J., Choi, W. S., and Lee, B. J., Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Mol. Cells, 31, 49-54 (2011).
32. Zaiou, M., Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J. Mol. Med., 85, 317-329 (2007).
33. Zasloff, M., Antimicrobial peptides of multicellular organisms. Nature, 415, 389-395 (2002).